Identifiers and status | First posted | Design | Participants | Interventions | Follow-up | Primary outcomes |
---|---|---|---|---|---|---|
NCT03962647; not yet recruiting | 24 May 2019 | Single-group assignment, clinical trial | 30 patients, ER+ breast cancer | Experimental: 2-week ketogenic diet | After 2 weeks of a ketogenic diet | Patients who complete the dietary intervention |
NCT03535701; recruiting | 24 May 2018 | Non-randomized, clinical trial | 15 patients with stage IV breast cancer (KETO-CARE) | Active comparator:aArm I (standard of care); Experimental: arm II (standard of care, ketogenic diet) | Baseline up to 26 weeks | Adherence and compliance to the ketogenic diet; Changes in psychosocial measures; Changes in physiological outcomes |
NCT02092753; completed | 20 March 2014 | Non-randomized, clinical trial | 150 patients with breast cancer during the rehabilitation phase | Placebo comparator: standard diet; Experimental: ketogenic diet; Experimental: logi diet | 20 weeks spanning 3 phases: 3 weeks of stationary intervention, 16 weeks of outhouse phase, and 1 final week of stationary intervention | Quality of life. This will be assessed by comparing the results of the EORTC QLQ-30 and the QLQ-BR23 questionnaires |